Sulforaphane inhibits osteoclastogenesis by inhibiting nuclear factor-kappaB. 2005

Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
Department of Biological Sciences, and Immunomodulation Research Center, University of Ulsan, Ulsan 680-749, Korea.

We show that sulforaphane inhibits osteoclastogenesis in the presence of macrophage colony-stimulating factor (M-CSF) and receptor for activation of nuclear factor-kB ligand (RANKL) in osteoclast (OC) precursors. Sulforaphane, an aliphatic isothiocyanate, is a known cancer chemo-preventative agent with anti-oxidative properties. Nuclear factor-kB (NF-kB) is a critical transcription factor in RANKL-induced osteoclastogenesis, and electrophoretic mobility shift assays (EMSAs) and assay of NF-kB-mediated secreted alkaline phosphatase (SEAP) revealed that sulforaphane selectively inhibited NF-kappaB activation induced by RANKL. Inhibition may involve interaction of sulforaphane with thiol groups, since it was prevented by reducing agents.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013438 Sulfhydryl Compounds Compounds containing the -SH radical. Mercaptan,Mercapto Compounds,Sulfhydryl Compound,Thiol,Thiols,Mercaptans,Compound, Sulfhydryl,Compounds, Mercapto,Compounds, Sulfhydryl
D013454 Sulfoxides Organic compounds that have the general formula R-SO-R. They are obtained by oxidation of mercaptans (analogous to the ketones). (From Hackh's Chemical Dictionary, 4th ed)

Related Publications

Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
January 2006, Clinical cancer research : an official journal of the American Association for Cancer Research,
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
March 2006, The Journal of biological chemistry,
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
June 2008, European journal of pharmacology,
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
April 2007, Sheng li xue bao : [Acta physiologica Sinica],
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
March 2005, Journal of endocrinological investigation,
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
January 2010, Molecular pharmacology,
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
November 2008, Molecules and cells,
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
September 2006, Molecular cancer research : MCR,
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
June 2003, Molecular pharmacology,
Soo-Jin Kim, and So-Young Kang, and Hyun-Hee Shin, and Hye-Seon Choi
March 2010, Critical care medicine,
Copied contents to your clipboard!